Richmond, VA, United States of America

Jin Koung Kim

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 1.4

ph-index = 4

Forward Citations = 70(Granted Patents)


Location History:

  • Fullerton, CA (US) (1995)
  • Santa Fe Springs, CA (US) (2016 - 2017)
  • Richmond, VA (US) (2022)

Company Filing History:


Years Active: 1995-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Jin Koung Kim: Innovator in Pharmaceutical Compositions

Introduction

Jin Koung Kim is a notable inventor based in Richmond, VA (US), recognized for his contributions to pharmaceutical compositions. With a total of six patents to his name, he has made significant strides in the field of medicine, particularly in the treatment of various diseases.

Latest Patents

Among his latest patents, Jin Koung Kim has developed compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salts thereof, combined with at least one cyclic oligosaccharide, such as cyclodextrin (CD). These innovative compositions are designed to prevent and treat a variety of diseases and conditions, including organ failure, high cholesterol, and various inflammatory diseases.

Career Highlights

Throughout his career, Jin Koung Kim has worked with Virginia Commonwealth University, where he has contributed to research and development in the pharmaceutical field. His work has been instrumental in advancing the understanding and treatment of critical health issues.

Collaborations

Jin Koung Kim has collaborated with notable colleagues, including Shunlin Ren and Leyuan Xu, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Jin Koung Kim's innovative work in pharmaceutical compositions showcases his dedication to improving health outcomes through scientific research. His contributions continue to influence the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…